Paragon spinout Apogee Therapeutics emerges with $169 million to expand team

Waltham, MA, December 7, 2022 (PRNewswire) -- Paragon Therapeutics, a biotechnology company dedicated to discovering and developing best-in-class biologics for a range of diseases with high unmet need, today announced the launch of Apogee Therapeutics, LLC, its first spinout. Apogee is advancing a pipeline of product candidates discovered and developed at Paragon that have potential to reach millions of people living with inflammatory and immunological disorders.

Read full article here.